ANGEL2
Protein angel homolog 2
Also known as: ANGE2_HUMAN, Ccr4d, FLJ12793, KIAA0759L
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5VTE6
- Gene
- ANGEL2
- Ensembl
- ENSG00000174606
- Chromosome
- 1
- Canonical length
- 544 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Mitochondria
OverviewNCBI Gene
Enables mRNA 3'-UTR binding activity. Involved in 3'-UTR-mediated mRNA stabilization and negative regulation of mitotic cell cycle. Located in Cajal body and cytoplasm. Is active in mitochondrial matrix. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
544 residues, UniProt reviewed canonical sequence.
>Q5VTE6|ANGEL2
1 MEAWRCVRKG YGHCVVGRGR YPMFPHHSRS LGRDWTTPWE NLQRCCWNRH ISSCMRWPGH
61 YSRAPYPYFS SRHFSLNWRP PCLFESRTQF QYCNWRPDNL SQTSLIHLSS YVMNAEGDEP
121 SSKRRKHQGV IKRNWEYICS HDKEKTKILG DKNVDPKCED SENKFDFSVM SYNILSQDLL
181 EDNSHLYRHC RRPVLHWSFR FPNILKEIKH FDADVLCLQE VQEDHYGAEI RPSLESLGYH
241 CEYKMRTGRK PDGCAICFKH SKFSLLSVNP VEFFRPDISL LDRDNVGLVL LLQPKIPYAA
301 CPAICVANTH LLYNPRRGDI KLTQLAMLLA EISSVAHQKD GSFCPIVMCG DFNSVPGSPL
361 YSFIKEGKLN YEGLPIGKVS GQEQSSRGQR ILSIPIWPPN LGISQNCVYE VQQVPKVEKT
421 DSDLTQTQLK QTEVLVTAEK LSSNLQHHFS LSSVYSHYFP DTGIPEVTTC HSRSAITVDY
481 IFYSAEKEDV AGHPGAEVAL VGGLKLLARL SLLTEQDLWT VNGLPNENNS SDHLPLLAKF
541 RLELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ANGEL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 15 nTPM
- cerebellum: 13 nTPM
- hippocampal formation: 11 nTPM
- amygdala: 11 nTPM
- lymph node: 9.8 nTPM
- breast: 9.7 nTPM
Single-cell type
- cardiomyocytes: 103 nCPM
- myonuclei: 77 nCPM
- adipocytes: 67 nCPM
- oligodendrocytes: 66 nCPM
- microglia: 65 nCPM
- prostatic glandular cells: 60 nCPM
Immune cell
- NK-cell: 11 nTPM
- T-reg: 8.9 nTPM
- naive CD4 T-cell: 6.7 nTPM
- basophil: 6.6 nTPM
- MAIT T-cell: 6.5 nTPM
- memory CD4 T-cell: 6.4 nTPM
Brain region
- basal ganglia: 23 nTPM
- hypothalamus: 20 nTPM
- amygdala: 20 nTPM
- hippocampal formation: 19 nTPM
- cerebral cortex: 18 nTPM
- white matter: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.88
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 3'-UTR-mediated mRNA stabilization
- negative regulation of mitotic cell cycle
- negative regulation of RNA splicing
- mitochondrial mRNA 3'-end processing
- negative regulation of tRNA processing
Molecular functions
- magnesium ion binding
- mRNA 3'-UTR binding
- RNA 2',3'-cyclic phosphatase activity
- RNA 2'-phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Endonuclease/exonuclease/phosphatase
- Endonuclease/exonuclease/phosphatase superfamily
- CCR4/nocturin mRNA turnover and transcription
- Endonuclease/Exonuclease/phosphatase family
- Protein angel homolog 2, N-terminal
- Protein angel homolog 2 N-terminal
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ANGEL2 as an antibody target. Whether an autoantibody or antibody against ANGEL2 could matter depends on whether native ANGEL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ANGEL2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ANGEL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...